Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Sep 9, 2011

Premium

At the Human Proteome Organization's 11th annual meeting this week in Geneva, the organization honored several proteomics researchers for their contributions to the field.

The awardees were: Mike Dunn – European Proteomics Association Senior Scientist Award in Proteomics; Amos Bairoch – HUPO Distinguished Achievement Award; Steven Carr – HUPO Discovery Award in Proteomics Sciences; He Fuchu – HUPO Distinguished Service Award; and Alexander Makarov – HUPO Science and Technology Award.

Dunn is Emeritus Professor of Biomedical Proteomics at University College Dublin as well as president of EuPA and vice-president of the British Society for Proteome Research. He was a founding council member of HUPO and is a member of the executive committee of the HUPO Human Brain Proteome Project and co-chair of the HUPO Cardiovascular Initiative.

Bairoch is the founder of the protein database Swiss-Prot as well as the Prosite and Enzyme resources and the recently launched NextProt database. He is the director of the Computer Analysis and Laboratory Investigation of Proteins of Human Origin group at the Swiss Institute of Bioinformatics and the University of Geneva.

Carr leads the proteomics platform at the Broad Institute of the Massachusetts Institute of Technology and Harvard University. Prior to joining the Broad he led the protein science and proteomics groups at Millennium Pharmaceuticals. He has over 125 publications on proteomics and biological mass spectrometry.

Fuchu is the president of Chinese HUPO and chair of HUPO's Human Liver Proteome Project. He is a professor at the Beijing Institute of Radiation Medicine and the director of the Chinese National Center of Biomedical Analysis.

Makarov is the director of global research for life sciences mass spectrometry at Thermo Fisher Scientific and one of the developers of the Orbitrap mass analyzer. He has authored more than 40 papers and holds more than 40 patents worldwide.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.